Sierra also retains the global commercialization rights to a portfolio of DNA Damage Response (DDR) assets, consisting of SRA737 and SRA141, and is conducting a campaign intended to seek non-dilutive strategic options to support their further advancement.
Please please do not listen to anyone on these boards. These guys are traders and that's how most of them make money by ramping/deramping shares.
Since morning this was meant to go touch the sky but in realty it has barely moved. I got caught few times previously but now understand their tricks. So don't just read here and invest. DYOR and follow your guts.
I would be more than happy to let them consolidate if: A - They invest substantial amount B - They disclose full status of both 401 and 201 and other products.
One target achieved. Now, to secure the compounds, let's plan a coupe. Kick the bod out and secure the asset's. I don't trust these people for a second.